{
  "links": "https://www.ycombinator.com/companies/velorum-therapeutics",
  "name": "Velorum Therapeutics",
  "headline": "Powerful cancer drugs that starve tumors",
  "batch": "W24",
  "description": "Velorum Therapeutics is developing a new class of cancer drugs that starve tumors by hijacking cancer metabolism.",
  "activity_status": "Active",
  "website": "https://www.velorumtx.com/",
  "founded_date": 2023.0,
  "team_size": 3.0,
  "location": "San Francisco",
  "group_partner": null,
  "group_partner_yc": null,
  "company_linkedin": null,
  "company_twitter": null,
  "tags": "industry:biotech; industry:healthcare; industry:therapeutics; industry:drug-discovery; industry:oncology; location:san-francisco-bay-area",
  "founders": [
    {
      "name": "Pouya Modareszadeh, Founder",
      "description": "Co-Founder & CEO of Velorum Therapeutics. BS in Biology, University of Texas at Dallas. Building new medicines.",
      "linkedin": "https://linkedin.com/in/pouya-modareszadeh"
    },
    {
      "name": "Parsa Modareszadeh, Founder",
      "description": "Co-Founder and President @ Velorum Therapeutics. Goldwater Scholar. Working to create breakthrough medicines for devastating diseases.",
      "linkedin": "https://linkedin.com/in/parsa-modareszadeh"
    }
  ],
  "status": true,
  "markdown": "raw_markdown=\"[](https://www.velorumtx.com/</>)\\n  * [Home](https://www.velorumtx.com/</>)\\n  * [About](https://www.velorumtx.com/</about>)\\n  * [Pipeline](https://www.velorumtx.com/</pipeline>)\\n  * [Patients](https://www.velorumtx.com/</patients>)\\n\\n\\n  * [Home](https://www.velorumtx.com/</>)\\n  * [About](https://www.velorumtx.com/</about>)\\n  * [Pipeline](https://www.velorumtx.com/</pipeline>)\\n  * [Patients](https://www.velorumtx.com/</patients>)\\n  * [News](https://www.velorumtx.com/</news>)\\n\\n\\n[NEWS](https://www.velorumtx.com/</news>)[](https://www.velorumtx.com/<#>)\\n# Unlocking the biology of heme to change lives.\\n[](https://www.velorumtx.com/<#intro>)\\n## The Biology of Heme\\nHeme is a crucial iron-containing molecule that sustains life through oxygen transport, energy generation, and cellular detoxification. Until now, heme as a target has been largely under-appreciated in drug development.\\n## Heme and Porphyrins\\nHeme is synthesized in developing red blood cells through an 8-step reaction. The precursors to heme are porphyrins, ringed organic molecules.\\n## Heme in disease\\nAs heme is a vital molecule, mistakes in heme synthesis or transport drive diseases such as porphyrias, cancer, and tissue injury.\\n![Plus icon](https://cdn.prod.website-files.com/678531a0a2dfbb893618b93d/6791062f19b84eb924dd80f8_circle-plus-200.svg)![Minus icon](https://cdn.prod.website-files.com/678531a0a2dfbb893618b93d/6791062f19b84eb924dd80f7_circle-minus-200.svg)\\nPorphyrias\\nInclude Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP). Mutations in heme synthesis enzymes lead to the toxic accumulation of heme precursors.\\n![Plus icon](https://cdn.prod.website-files.com/678531a0a2dfbb893618b93d/6791062f19b84eb924dd80f8_circle-plus-200.svg)![Minus icon](https://cdn.prod.website-files.com/678531a0a2dfbb893618b93d/6791062f19b84eb924dd80f7_circle-minus-200.svg)\\nCancer\\nOverdrive of heme consumption by tumors fuels cancer growth and progression.\\n![Plus icon](https://cdn.prod.website-files.com/678531a0a2dfbb893618b93d/6791062f19b84eb924dd80f8_circle-plus-200.svg)![Minus icon](https://cdn.prod.website-files.com/678531a0a2dfbb893618b93d/6791062f19b84eb924dd80f7_circle-minus-200.svg)\\nHeme Injury\\nThe release of heme as a result of tissue damage or disease causes toxic effects on multiple organs, including the kidneys, heart, and liver.\\n## We are creating transformational medicines by unlocking the biology of heme.\\nOur pipeline of innovative therapies is focused on empowering new horizons for patients with unmet needs.\\n[EXPLORE OUR PIPELINE](https://www.velorumtx.com/</pipeline>)\\nWe are laser-focused on bringing transformative medicines to patients. \\n[Learn more info](https://www.velorumtx.com/</patients>)\\n![A silhouette of a person with open arms embracing the sunrise, symbolizing hope, renewal, and Velorum Therapeutics' commitment to transformative medicines.](https://cdn.prod.website-files.com/678531a0a2dfbb893618b93d/679757e7ab0dbc5fe723b39a_Photo.avif)\\n[](https://www.velorumtx.com/</>)\\n329 Oyster Point Blvd 3rd Floor, South San Francisco, CA 94080\\ninfo@velorumtx.com\\n[](https://www.velorumtx.com/<https:/x.com/velorumtx>)[](https://www.velorumtx.com/<https:/www.linkedin.com/company/velorumtx>)\\n[Privacy Policy](https://www.velorumtx.com/</privacy-policy>)\\n© 2025 Velorum Therapeutics Inc.\\n![](https://cdn.prod.website-files.com/678531a0a2dfbb893618b93d/6787b6f3365843d1227b93e3_VelorumBoat.avif)\\n\" markdown_with_citations=\"[](https://www.velorumtx.com/</>)\\n  * Home⟨1⟩\\n  * About⟨2⟩\\n  * Pipeline⟨3⟩\\n  * Patients⟨4⟩\\n\\n\\n  * Home⟨1⟩\\n  * About⟨2⟩\\n  * Pipeline⟨3⟩\\n  * Patients⟨4⟩\\n  * News⟨5⟩\\n\\n\\nNEWS⟨5⟩[](https://www.velorumtx.com/<#>)\\n# Unlocking the biology of heme to change lives.\\n[](https://www.velorumtx.com/<#intro>)\\n## The Biology of Heme\\nHeme is a crucial iron-containing molecule that sustains life through oxygen transport, energy generation, and cellular detoxification. Until now, heme as a target has been largely under-appreciated in drug development.\\n## Heme and Porphyrins\\nHeme is synthesized in developing red blood cells through an 8-step reaction. The precursors to heme are porphyrins, ringed organic molecules.\\n## Heme in disease\\nAs heme is a vital molecule, mistakes in heme synthesis or transport drive diseases such as porphyrias, cancer, and tissue injury.\\n![Plus icon⟨6⟩]![Minus icon⟨7⟩]\\nPorphyrias\\nInclude Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP). Mutations in heme synthesis enzymes lead to the toxic accumulation of heme precursors.\\n![Plus icon⟨6⟩]![Minus icon⟨7⟩]\\nCancer\\nOverdrive of heme consumption by tumors fuels cancer growth and progression.\\n![Plus icon⟨6⟩]![Minus icon⟨7⟩]\\nHeme Injury\\nThe release of heme as a result of tissue damage or disease causes toxic effects on multiple organs, including the kidneys, heart, and liver.\\n## We are creating transformational medicines by unlocking the biology of heme.\\nOur pipeline of innovative therapies is focused on empowering new horizons for patients with unmet needs.\\nEXPLORE OUR PIPELINE⟨3⟩\\nWe are laser-focused on bringing transformative medicines to patients. \\nLearn more info⟨4⟩\\n![A silhouette of a person with open arms embracing the sunrise, symbolizing hope, renewal, and Velorum Therapeutics' commitment to transformative medicines.⟨8⟩]\\n[](https://www.velorumtx.com/</>)\\n329 Oyster Point Blvd 3rd Floor, South San Francisco, CA 94080\\ninfo@velorumtx.com\\n[](https://www.velorumtx.com/<https:/x.com/velorumtx>)[](https://www.velorumtx.com/<https:/www.linkedin.com/company/velorumtx>)\\nPrivacy Policy⟨9⟩\\n© 2025 Velorum Therapeutics Inc.\\n![](https://cdn.prod.website-files.com/678531a0a2dfbb893618b93d/6787b6f3365843d1227b93e3_VelorumBoat.avif)\\n\" references_markdown=\"\\n\\n## References\\n\\n⟨1⟩ https://www.velorumtx.com/</>: Home\\n⟨2⟩ https://www.velorumtx.com/</about>: About\\n⟨3⟩ https://www.velorumtx.com/</pipeline>: Pipeline\\n⟨4⟩ https://www.velorumtx.com/</patients>: Patients\\n⟨5⟩ https://www.velorumtx.com/</news>: News\\n⟨6⟩ https://cdn.prod.website-files.com/678531a0a2dfbb893618b93d/6791062f19b84eb924dd80f8_circle-plus-200.svg: Plus icon\\n⟨7⟩ https://cdn.prod.website-files.com/678531a0a2dfbb893618b93d/6791062f19b84eb924dd80f7_circle-minus-200.svg: Minus icon\\n⟨8⟩ https://cdn.prod.website-files.com/678531a0a2dfbb893618b93d/679757e7ab0dbc5fe723b39a_Photo.avif: A silhouette of a person with open arms embracing the sunrise, symbolizing hope, renewal, and Velorum Therapeutics' commitment to transformative medicines.\\n⟨9⟩ https://www.velorumtx.com/</privacy-policy>: Privacy Policy\\n\" fit_markdown='' fit_html=''",
  "generated_description": "**Velorum Therapeutics: Sparking Hope in Oncology**\n\nFounded in 2023 and situated in the vibrant San Francisco Bay Area, Velorum Therapeutics is making waves as a groundbreaking biotech company. Its mission? To develop powerful cancer drugs that literally starve tumors by tapping into the intricacies of cancer metabolism. This approach represents a fresh perspective in oncology, aiming to disrupt the status quo in cancer treatment.\n\nAs a member of the Y Combinator W24 cohort, Velorum is backed by one of the most prestigious accelerator programs in the world, which adds a layer of credibility to its innovative endeavors. The company currently operates with a lean team of three passionate employees, focusing on bringing cutting-edge cancer therapies to the forefront of medical science.\n\nAt the heart of Velorum’s strategy is a keen emphasis on heme biology. The company recognizes that heme—a crucial iron-containing molecule—plays a fundamental role in vital biological processes such as oxygen transport and energy generation. Unfortunately, this essential molecule has been overlooked in traditional drug development. Velorum aims to change that.\n\nCancer, as we've learned, often exploits bodily resources to fuel its growth, and heme is no exception. By understanding and manipulating how tumors consume heme, Velorum is on the path to developing therapies that can starve these malignant cells. Their pipeline of innovative treatments is tailored towards patients with urgent medical needs, potentially offering new options where few exist.\n\nIf you want to explore Velorum Therapeutics more or have the uneasy pleasure of diving into their ambitious vision, check out their website [here](https://www.velorumtx.com). This is not just another biotech—this is a company with a mission to transform the narratives surrounding cancer treatment and patient care. In a world often starved for innovation, Velorum Therapeutics stands as a beacon of hope."
}